(l-r) Naval Inspector General Vice Adm. Michael Baze, US 7th Fleet commander Vice Adm. Patrick Hannifin The new Naval Inspector General and U.S. 7th Fleet commander took command this week following ...
Vice Adm. Patrick Hannifin, left, assumes command of the U.S. 7th Fleet at a ceremony in Yokosuka, Japan, on Nov. 13, replacing Vice Adm. Fred Kacher, right. (MCS Charles Oki/U.S. Navy) The world’s ...
The Blue Oval is eager to capture sales from Chevrolet. It’s clear that significant time, effort, and investment were put into the 2025 Ford Expedition to help it steal some sales away from the Chevy ...
If you had told me that a debut double-A game from a studio of largely unknown developers would be one of the biggest contenders for the Game of the Year awards in 2025, as well as one of the best ...
Whether you love or hate Magic's Universes Beyond lineup, it's hard to deny how excellent the Avatar: The Last Airbender set is looking so far. Everything I've seen is filling me with confidence, so ...
Admiral Alvin Holsey, who has led U.S. military efforts in Latin America for less than a year, will step down as commander of U.S. Southern Command (SOUTHCOM) at the end of 2025, marking another ...
The commander of U.S. Southern Command (SOUTHCOM), whose area of operations includes the Caribbean waters where the strikes against the alleged drug boats have been conducted, announced he is retiring ...
Navy Adm. Alvin Holsey testifies before senators in 2024 about his appointment as commander of U.S. Southern Command. (Tech. Sgt. Sarah M. McClanahan/Air National Guard) Editor’s note: This is a ...
Allison DeAngelis is the East Coast biotech and venture capital reporter at STAT, reporting where scientific ideas and money meet. She is also co-host of the weekly biotech podcast, The Readout Loud.
Atlassian Corp. today announced plans to acquire DX, a startup with a software platform that helps enterprises make their developers more productive. The deal is worth about $1 billion. Atlassian ...
The jet set are flocking to the water as luxury expedition cruising becomes the hottest trend in luxury travel—cruising that involves intimate groups on elegant ships with fine wine, butlers, ...
Young inflammatory disease biotech Expedition Therapeutics is paying $17 million cash for licensing rights to an investigational DPP-1 inhibitor from Fosun Pharma. Shanghai-based Fosun is handing over ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results